Time-Restricted Mediterranean Diet Shows Promise for MASLD
The Mediterranean diet, combined with early time-restricted feeding, reduces A1c levels and insulin resistance in patients with MASLD and overweight or obesity.
The Mediterranean diet, combined with early time-restricted feeding, reduces A1c levels and insulin resistance in patients with MASLD and overweight or obesity.
A new study provides the strongest evidence to date on the clinical utility of a polygenic score for prostate cancer screening, one expert says, but…
When a patient with obesity reports a new symptom, many physicians are quick to focus on the excess weight without exploring alternative reasons. Wrong approach,…
Two early-phase clinical trials demonstrate the safety and potential clinical utility of stem cell therapies to ease motor symptoms associated with Parkinson’s disease.
A modeling study estimates that just over 100,000 cancers in the US are predicted to result from radiation from the 93 million CT examinations performed…
The new name and endorsement at the World Diabetes Congress are seen as long-overdue recognition that will spur more research.
Will artificial intelligence finally streamline the cumbersome prior authorization process — or just add a new layer of complexity to the chaos?
Stay current, stay connected—enhance your nasopharyngeal carcinoma expertise with the latest in immunotherapy and multidisciplinary strategies.
Over 50% of patients with disorders of gut-brain interaction experience carbohydrate intolerance, and these patients report more severe IBS symptoms than those without intolerance.
MedscapeLIVE! Presents A Whole New Ballgame: Medscape is pleased to present five live symposia at the Manchester Grand Hyatt in San Diego, CA on May…